These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6111224)

  • 21. Functionally distinct muscarinic receptors on gastric somatostatin cells.
    Schubert ML; Hightower J
    Am J Physiol; 1990 Jun; 258(6 Pt 1):G982-7. PubMed ID: 1972864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
    McIntosh CH; Jia X; Kowk YN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of dopamine and dopaminergic agonists on the contractions of field stimulated rat vas deferens.
    György L; Orr Z; Folly G; Dóda M
    Arch Int Pharmacodyn Ther; 1981 Mar; 250(1):55-64. PubMed ID: 6268006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bromocriptine on pancreatic secretion in the isolated, blood-perfused pancreas of the dog.
    Iwatsuki K; Iijima F; Chiba S
    Clin Exp Pharmacol Physiol; 1984; 11(3):231-5. PubMed ID: 6744683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Calcitonin gene-related peptide stimulates somatostatin release from isolated perfused rat stomach.
    Yamatani T; Kadowaki S; Chiba T; Abe H; Chihara K; Fukase M; Fujita T
    Endocrinology; 1986 May; 118(5):2144-5. PubMed ID: 2870914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of the sympathetic nervous system on bethanechol-induced elevation of gastric acid secretion and mucosal blood flow in rats.
    Yokotani K; Muramatsu I; Fujiwara M
    J Pharmacol Exp Ther; 1983 Nov; 227(2):478-83. PubMed ID: 6313905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control of rat gastric somatostatin release by gamma-aminobutyric acid (GABA).
    Koop H; Arnold R
    Horm Metab Res; 1986 Feb; 18(2):94-7. PubMed ID: 2870970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of gastric acid secretion in rat stomach by PACAP is mediated by secretin, somatostatin, and PGE(2).
    Li P; Chang TM; Coy D; Chey WY
    Am J Physiol Gastrointest Liver Physiol; 2000 Jan; 278(1):G121-7. PubMed ID: 10644570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of the relaxing effect of dopamine on the isolated rat jejunum.
    Lucchelli A; Boselli C; Chiari MC; Grana E
    Arch Int Pharmacodyn Ther; 1986 Feb; 279(2):234-47. PubMed ID: 3963938
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vagal regulation of GRP, gastric somatostatin, and gastrin secretion in vitro.
    Nishi S; Seino Y; Takemura J; Ishida H; Seno M; Chiba T; Yanaihara C; Yanaihara N; Imura H
    Am J Physiol; 1985 Apr; 248(4 Pt 1):E425-31. PubMed ID: 2858978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alpha 2-receptor-mediated inhibition of intraluminal release of gastric somatostatin in anaesthetized rats.
    Aliño SF; Garcia D; Uvnäs-Moberg K
    Acta Physiol Scand; 1992 Mar; 144(3):233-8. PubMed ID: 1350163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine stimulates somatostatin release from perifused hypothalamic cells.
    Richardson SB; Nguyen T; Hollander CS
    Am J Physiol; 1983 Jun; 244(6):E560-6. PubMed ID: 6134472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro evidence for dopaminergic receptors in human renal artery.
    Ueda S; Yano S; Sakanashi M
    J Cardiovasc Pharmacol; 1982; 4(1):76-81. PubMed ID: 6176804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of alterations in the pituitary-thyroid axis on hypothalamic content and in vitro release of somatostatin-like immunoreactivity.
    Berelowitz M; Maeda K; Harris S; Frohman LA
    Endocrinology; 1980 Jul; 107(1):24-9. PubMed ID: 6103803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of catecholamines in the ketonemic response to somatostatin in normal man.
    Beaufrere B; Beylot M; Riou JP; Serusclat P; Cohen R; Souquet JC; Mornex R
    J Clin Endocrinol Metab; 1983 Oct; 57(4):847-50. PubMed ID: 6136524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Stimulation of somatostatin release in vitro by synthetic human growth hormone-releasing factor by a nondopaminergic mechanism.
    Aguila MC; McCann SM
    Endocrinology; 1985 Aug; 117(2):762-5. PubMed ID: 2862013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of enzyme inhibitors of catecholamine metabolism and of haloperidol on the pancreatic secretion induced by L-DOPA and by dopamine in dogs.
    Furuta Y; Hashimoto K; Iwatsuki K; Takeuchi O
    Br J Pharmacol; 1973 Jan; 47(1):77-84. PubMed ID: 4717022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of alpha, beta, and dopamine receptor-blocking agents on the stimulation of rat erythrocyte adenyl cyclase by dihydroxyphenethylamines and their beta-hydroxylated derivatives.
    Sheppard H; Burghardt CR
    Mol Pharmacol; 1971 Jan; 7(1):1-7. PubMed ID: 5552248
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypothalamic D2 receptors mediate the preferential release of somatostatin-28 in response to dopaminergic stimulation.
    Lewis BM; Dieguez C; Lewis M; Hall R; Scanlon MF
    Endocrinology; 1986 Oct; 119(4):1712-7. PubMed ID: 2428601
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of peptide YY on gastric acid secretion, gastrin and somatostatin release in the rat.
    Eissele R; Koop H; Arnold R
    Z Gastroenterol; 1990 Mar; 28(3):129-31. PubMed ID: 1971469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.